William H. Jackson

502 total citations
10 papers, 420 citations indexed

About

William H. Jackson is a scholar working on Molecular Biology, Genetics and Epidemiology. According to data from OpenAlex, William H. Jackson has authored 10 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Genetics and 2 papers in Epidemiology. Recurrent topics in William H. Jackson's work include Autophagy in Disease and Therapy (2 papers), Virus-based gene therapy research (2 papers) and CRISPR and Genetic Engineering (2 papers). William H. Jackson is often cited by papers focused on Autophagy in Disease and Therapy (2 papers), Virus-based gene therapy research (2 papers) and CRISPR and Genetic Engineering (2 papers). William H. Jackson collaborates with scholars based in United States. William H. Jackson's co-authors include Patricia V. Schoenlein, Sudharsan Periyasamy‐Thandavan, Julia S. Samaddar, David T. Curiel, Claudine Rancourt, Meizhen Feng, John T. Barrett, Gene P. Siegal, Minghui Wang and Corey K. Goldman and has published in prestigious journals such as Nature Biotechnology, Cancer Research and The FASEB Journal.

In The Last Decade

William H. Jackson

10 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William H. Jackson United States 9 291 171 115 88 38 10 420
M M Georgescu United States 5 257 0.9× 48 0.3× 55 0.5× 87 1.0× 59 1.6× 6 398
Anusara Daenthanasanmak United States 15 188 0.6× 52 0.3× 56 0.5× 175 2.0× 40 1.1× 27 607
Irina Dobromilskaya United States 9 431 1.5× 37 0.2× 131 1.1× 266 3.0× 86 2.3× 10 633
Shwu‐Yuan Wu United States 11 739 2.5× 160 0.9× 165 1.4× 201 2.3× 66 1.7× 16 958
Ni Sima China 11 259 0.9× 75 0.4× 127 1.1× 121 1.4× 95 2.5× 20 463
Nicolas Stankovic‐Valentin Germany 13 617 2.1× 53 0.3× 83 0.7× 202 2.3× 83 2.2× 15 720
Daniel W. Sharp United States 3 227 0.8× 34 0.2× 210 1.8× 55 0.6× 94 2.5× 4 370
Esha Sachdev United States 7 144 0.5× 100 0.6× 35 0.3× 166 1.9× 47 1.2× 9 382
Lisa Lirussi Norway 13 631 2.2× 48 0.3× 30 0.3× 125 1.4× 76 2.0× 22 708
P B Rowe Australia 11 322 1.1× 56 0.3× 54 0.5× 89 1.0× 22 0.6× 21 493

Countries citing papers authored by William H. Jackson

Since Specialization
Citations

This map shows the geographic impact of William H. Jackson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William H. Jackson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William H. Jackson more than expected).

Fields of papers citing papers by William H. Jackson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William H. Jackson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William H. Jackson. The network helps show where William H. Jackson may publish in the future.

Co-authorship network of co-authors of William H. Jackson

This figure shows the co-authorship network connecting the top 25 collaborators of William H. Jackson. A scholar is included among the top collaborators of William H. Jackson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William H. Jackson. William H. Jackson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Periyasamy‐Thandavan, Sudharsan, Adam D. Singer, Michael R. Dohn, et al.. (2012). Insulin-like growth factor 1 attenuates antiestrogen- and antiprogestin-induced apoptosis in ER+ breast cancer cells by MEK1 regulation of the BH3-only pro-apoptotic protein Bim. Breast Cancer Research. 14(2). R52–R52. 22 indexed citations
2.
Periyasamy‐Thandavan, Sudharsan, et al.. (2011). Abstract 2: IGF-1 attenuates antiestrogen- and antiprogestin-induced apoptosis in ER + breast cancer cells by MEK1 regulation of the BH3-only pro-apoptotic protein Bim. Cancer Research. 71(8_Supplement). 2–2. 9 indexed citations
4.
Schoenlein, Patricia V., Sudharsan Periyasamy‐Thandavan, Julia S. Samaddar, William H. Jackson, & John T. Barrett. (2009). Autophagy facilitates the progression of ERα-positive breast cancer cells to antiestrogen resistance. Autophagy. 5(3). 400–403. 111 indexed citations
5.
Jackson, William H., et al.. (1998). Inhibition of HIV-1 Replication by an Anti-tat Hammerhead Ribozyme. Biochemical and Biophysical Research Communications. 245(1). 81–84. 13 indexed citations
6.
Turner, Timothy, William H. Jackson, George R. Pettit, Alan Wells, & Andrew S. Kraft. (1998). Treatment of human prostate cancer cells with dolastatin 10, a peptide isolated from a marine shell‐less mollusc. The Prostate. 34(3). 175–181. 2 indexed citations
7.
Jackson, William H., et al.. (1998). Treatment of human prostate cancer cells with dolastatin 10, a peptide isolated from a marine shell-less mollusc. The Prostate. 34(3). 175–181. 32 indexed citations
8.
Feng, Meizhen, William H. Jackson, Corey K. Goldman, et al.. (1997). Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector. Nature Biotechnology. 15(9). 866–870. 111 indexed citations
9.
Bilbao, Guadalupe, Meizhen Feng, Claudine Rancourt, William H. Jackson, & David T. Curiel. (1997). Adenoviral/retroviral vector chimeras: a novel strategy to achieve high‐efficiency stable transduction in vivo. The FASEB Journal. 11(8). 624–634. 51 indexed citations
10.
Lorber, A, William H. Jackson, & Timothy M. Simon. (1981). Assessment of Immune Response During Chrysotherapy: Comparison of Gold Sodium Thiomalate vs. Auranofin. Scandinavian Journal of Rheumatology. 10(2). 129–137. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026